are semaglutide being banned Critics debating whether GLP-1 drugs should be in sports for potentially performance-enhancing drugs. (Photo: Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) FDA Ban on Compounded GLP-1

Mega Doctor News Medical News Today Stomach pain is a common side effect of Wegovy (semaglutide) that affects approximately 20% of patients in clinical trials

Outcomes were analysed using mixed-effects ANCOVA and cluster-based permutation testing

Lesser-Known & Emerging Side Effects Patients and clinicians are reporting symptoms not always discussed at the start: Cognitive issues : memory problems, brain fog, difficulty concentrating Speech changes : word-finding difficulty, unclear speech Hair thinning or loss Vision or hearing changes Ozempic face : hollowed cheeks, sagging skin, more visible wrinkles due to rapid fat loss While some may be linked to rapid weight loss and nutrient deficiencies, these changes can feel alarming, especially with long-term use

This is allowed because it's not available commercially

The mood in Israel is wavering between anxiety, resignation and anticipation

TIRZEPATIDE Tirzepatide is a dual receptor agonist of the glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 and is therefore referred to as a twincretin. 28,29 Tirzepatide is a 39 amino acid-long synthetic peptide, the structure of which is based on that of the native GIP